长风药业转战港交所:单一产品依赖且面临集采降价风险 累亏超8亿靠带金销售换增长?

新浪财经
Sep 23

来源:视频滚动新闻长风药业向港交所递上市申请。此前两次科创板上市无果。公司营收依赖单一产品,净利率低,销售费用高,面临集采续约等风险,尚存在大额累亏,此次港交所IPO能否成功存疑。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10